Sign up to save your podcasts
Or
Share Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization
Host: Linda Bernstein, Pharm.D.
The U.S. Food and Drug Administration has granted Eli Lilly and Company’s trial vaccine for COVID-19 an Emergency Use Authorization, or EUA. On this episode of The Drug Report, learn more about this monoclonal antibody and how the company plans on distributing it.
Published November 30, 2020
View all episodes
By ReachMDHost: Linda Bernstein, Pharm.D.
The U.S. Food and Drug Administration has granted Eli Lilly and Company’s trial vaccine for COVID-19 an Emergency Use Authorization, or EUA. On this episode of The Drug Report, learn more about this monoclonal antibody and how the company plans on distributing it.
Published November 30, 2020